<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF9CB968-444F-4235-8563-AAD6B542FC41"><gtr:id>BF9CB968-444F-4235-8563-AAD6B542FC41</gtr:id><gtr:name>The Alliance</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/679E3226-7E46-4F18-90B6-0B4FE734C099"><gtr:id>679E3226-7E46-4F18-90B6-0B4FE734C099</gtr:id><gtr:name>Glasgow Caledonian University</gtr:name><gtr:address><gtr:line1>70 Cowcaddens Road</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G4 0BA</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C3A3D9C-2AAF-42B6-ABEF-259677C4D8E4"><gtr:id>3C3A3D9C-2AAF-42B6-ABEF-259677C4D8E4</gtr:id><gtr:name>NHS National Services Scotland (NSS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3F651397-D954-4B0D-BD90-E60FB648675E"><gtr:id>3F651397-D954-4B0D-BD90-E60FB648675E</gtr:id><gtr:name>Information Services Division (ISD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E5648B13-2D3E-4580-BE96-54B19BDE9B6F"><gtr:id>E5648B13-2D3E-4580-BE96-54B19BDE9B6F</gtr:id><gtr:name>Crime Reduction Initiatives (CRI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8A9F5126-6D56-4C85-8FF5-2CDE7ABFC4FF"><gtr:id>8A9F5126-6D56-4C85-8FF5-2CDE7ABFC4FF</gtr:id><gtr:name>Ministry of Justice</gtr:name><gtr:address><gtr:line1>Selborne House</gtr:line1><gtr:line2>54 Victoria Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW1E 6QW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF9CB968-444F-4235-8563-AAD6B542FC41"><gtr:id>BF9CB968-444F-4235-8563-AAD6B542FC41</gtr:id><gtr:name>The Alliance</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/679E3226-7E46-4F18-90B6-0B4FE734C099"><gtr:id>679E3226-7E46-4F18-90B6-0B4FE734C099</gtr:id><gtr:name>Glasgow Caledonian University</gtr:name><gtr:address><gtr:line1>70 Cowcaddens Road</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G4 0BA</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C3A3D9C-2AAF-42B6-ABEF-259677C4D8E4"><gtr:id>3C3A3D9C-2AAF-42B6-ABEF-259677C4D8E4</gtr:id><gtr:name>NHS National Services Scotland (NSS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3F651397-D954-4B0D-BD90-E60FB648675E"><gtr:id>3F651397-D954-4B0D-BD90-E60FB648675E</gtr:id><gtr:name>Information Services Division (ISD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E5648B13-2D3E-4580-BE96-54B19BDE9B6F"><gtr:id>E5648B13-2D3E-4580-BE96-54B19BDE9B6F</gtr:id><gtr:name>Crime Reduction Initiatives (CRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A9F5126-6D56-4C85-8FF5-2CDE7ABFC4FF"><gtr:id>8A9F5126-6D56-4C85-8FF5-2CDE7ABFC4FF</gtr:id><gtr:name>Ministry of Justice</gtr:name><gtr:address><gtr:line1>Selborne House</gtr:line1><gtr:line2>54 Victoria Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW1E 6QW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/957175EE-D90E-4C8F-B753-192D114FF12E"><gtr:id>957175EE-D90E-4C8F-B753-192D114FF12E</gtr:id><gtr:firstName>Ruth</gtr:firstName><gtr:surname>King</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D7D2CD93-3F26-4C0D-86B7-83BBB540D8B1"><gtr:id>D7D2CD93-3F26-4C0D-86B7-83BBB540D8B1</gtr:id><gtr:firstName>Sheila</gtr:firstName><gtr:otherNames>Macdonald</gtr:otherNames><gtr:surname>Bird</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6385D3D0-51EB-42B4-B15C-7AE95A0D30A6"><gtr:id>6385D3D0-51EB-42B4-B15C-7AE95A0D30A6</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Marsden</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/00FD6AA2-05F7-496D-B825-61F2CD8CDD16"><gtr:id>00FD6AA2-05F7-496D-B825-61F2CD8CDD16</gtr:id><gtr:firstName>A E</gtr:firstName><gtr:surname>Ades</gtr:surname><gtr:orcidId>0000-0001-7822-3552</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CB30D12D-6305-48C6-AED0-641F3D22D0EF"><gtr:id>CB30D12D-6305-48C6-AED0-641F3D22D0EF</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:surname>Hickman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/81DE8EBD-E622-4740-84DF-FDD13B0B39F6"><gtr:id>81DE8EBD-E622-4740-84DF-FDD13B0B39F6</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Millar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/52FBB41A-40E3-4DD3-A973-556FE141935B"><gtr:id>52FBB41A-40E3-4DD3-A973-556FE141935B</gtr:id><gtr:firstName>Charlie</gtr:firstName><gtr:surname>Lloyd</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5033A559-126A-4C8C-9798-8FDCC4C74ACD"><gtr:id>5033A559-126A-4C8C-9798-8FDCC4C74ACD</gtr:id><gtr:firstName>Nicky</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Welton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/26F77E16-8B08-4A86-9A87-8CFCD60D0329"><gtr:id>26F77E16-8B08-4A86-9A87-8CFCD60D0329</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Dunn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FD131C5D-282D-43A3-A5D3-88C0789B92CA"><gtr:id>FD131C5D-282D-43A3-A5D3-88C0789B92CA</gtr:id><gtr:firstName>Linda</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E99E4AC-E967-4AC0-9421-DA4C2CCE4C48"><gtr:id>1E99E4AC-E967-4AC0-9421-DA4C2CCE4C48</gtr:id><gtr:firstName>Toby</gtr:firstName><gtr:surname>Seddon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CFB7D585-9303-4E27-A864-631C61A62C57"><gtr:id>CFB7D585-9303-4E27-A864-631C61A62C57</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Donmall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9E500403-291B-4FE4-AB79-023730242F30"><gtr:id>9E500403-291B-4FE4-AB79-023730242F30</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Buchan</gtr:surname><gtr:orcidId>0000-0003-3392-1650</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A2EBF382-1694-4A20-91D5-C32B1952DB35"><gtr:id>A2EBF382-1694-4A20-91D5-C32B1952DB35</gtr:id><gtr:firstName>Christine</gtr:firstName><gtr:surname>Godfrey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02AFEF84-23B9-4761-B983-900606111761"><gtr:id>02AFEF84-23B9-4761-B983-900606111761</gtr:id><gtr:firstName>Sharon</gtr:firstName><gtr:surname>hutchinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2BD47C61-5096-4B3F-AE14-EBB61F65680B"><gtr:id>2BD47C61-5096-4B3F-AE14-EBB61F65680B</gtr:id><gtr:firstName>Daniela</gtr:firstName><gtr:surname>DeAngelis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000021"><gtr:id>C2D79DC4-3DA2-4B08-B230-367D7AA325B4</gtr:id><gtr:title>Incidence, prevalence, harms and intervention effects for problem and injecting drug use: crime, morbidity &amp;amp; mortality</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000021</gtr:grantReference><gtr:abstractText>Drug misuse causes severe problems for society, communities, and families and incurs huge economic costs. UK Government estimates suggest somewhere between #9 and #15 billion, in England and Wales alone, during 2000, and perhaps up to #16 billion during 2003/04. Most of this cost related to an estimated 330,000 people who had very severe problems with addiction to drugs like heroin and crack. The most recent economic estimates (2003/04) suggest that these people accounted for 99% of the total cost and that their crime accounted for 90% of the costs they generated. Drug misuse is also the third most common cause of death for people aged 15-34, mainly because of overdose from drugs like heroin. A lot of taxpayers? money is spent in trying to address these problems, but estimates of the number of drug users and associated problems have not been routinely or consistently available to help governments to make the best policy choices and it is difficult to be sure how certain the estimates are, because they relate to different time-periods. Our research will combine, and then compare, different sorts of information about serious drug problems to get a more exact idea of how many people are involved, how many get involved in crime, what proportion die, and how helpful treatment has been in reducing death and crime. Instead of just relying on how well people can remember their crimes, which is the approach that research studies have taken in the past, we will use treatment records and criminal records to see exactly when they were arrested and if any crimes happened while they being treated, or not. We will use a similar approach to look at death registrations. We will use statistical analysis to improve estimates of how many people have had severe drug problems, to learn whether more of these have died, and from what causes, and to discover whether this problem is worse in some areas than others. Using advanced statistical techniques, we will examine all of the available sources of information about drug misuse and bring these together to test whether they are consistent, to find out why inconsistencies occur, and to adjust the estimates to allow for any inconsistencies that we find. Our findings will provide the Government with much better estimates, to help to make decisions about how to deal with the drug problem and how to spend public money wisely.</gtr:abstractText><gtr:technicalSummary>Decisions about drug policy are based on estimates of harms, prevalence, and intervention effects that are imprecise, sometimes inconsistent, and lack cross-validation. There is a need to develop more precise, better validated, and consistent estimates of key harms associated with Problem and Injecting Drug Use (P/IDU), and of the effects of treatment intervention, in order to provide a sound basis for policy decisions. The proposed research will examine the prevalence of P/IDU and key harms within three related strands. Strand A will analyse data for a virtual cohort (n=320,000) of PDUs in England, already assembled within work for the Home Office, to explore the timing of crime and mortality events in relation to evolving treatment status. This will provide a novel and more precise assessment of the magnitude and temporal persistence of treatment effects in reducing crime and mortality than has, hitherto, been available. Strand A recognises the cyclical nature of addiction treatment and avoids the difficulties inherent in self-report data. Findings about patients and circumstances that constitute a higher risk in terms of mortality or recidivism will have a direct bearing on treatment policy and practice and will inform work in Strand C. Strand B will apply Bayesian approaches to demographical IDU prevalence estimation with a view to comparison of IDUs? drug-related death rates; and will test the application of this approach to a common set of national sources for Scotland, reflecting the economically efficient approach taken in England Strand B will also explore regional trends in IDUs? drug-related death rates, with England as comparator, and so determine whether IDUs? death-rates by age-group and sex are regionally and nationally consistent. If not, questions about the differential effectiveness of IDU-related harm reduction policies may be posed. Strand C is the first comprehensive attempt simultaneously to model P/IDU prevalence, mortality and crime data together, using a Multi Parameter Evidence Synthesis framework. It will test the consistency of the available data and produce a coherent model, for England, of drug use, mortality and crime, cross-validated by several entirely independent data sources, to better inform policy development. Methods and results will have wider application in areas such as alcohol dependency. We will place particular emphasis on dissemination of results to policy and practitioner audiences, as well as via peer-review journals.</gtr:technicalSummary><gtr:fund><gtr:end>2014-12-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>697651</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Performance and productivity of community substance misuse treatment services</gtr:description><gtr:id>8B731135-B22F-438F-B3AD-CB939CBE0761</gtr:id><gtr:impact>Grant application in submission</gtr:impact><gtr:outcomeId>5458d578a3d117.16651448-1</gtr:outcomeId><gtr:partnerContribution>Expertise re non-medical prescribing</gtr:partnerContribution><gtr:piContribution>Expertise re analysis of secondary datasets on drug misuse treatment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Health and Social Impact on Children Who Experience Serious Parental Alcohol Misuse</gtr:description><gtr:id>7D522A27-9289-43AE-B422-B5B577BE7B91</gtr:id><gtr:impact>Grant application submitted, unsuccessful.</gtr:impact><gtr:outcomeId>5458d8b441c180.76853675-2</gtr:outcomeId><gtr:partnerContribution>Expertise in the analysis of linked Scandinavian datasets &amp;amp; in alcohol research</gtr:partnerContribution><gtr:piContribution>Expertise in the analysis of linked secondary datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Information Services Division (ISD)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of impact of Scotland's in-prison methadone programme on drugs-related deaths</gtr:description><gtr:id>8678F928-012E-4A49-B38D-DD6F27A7AB03</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:outcomeId>W1MQ6fV5H8J-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>Bird, with Dr Colin Fischbacher, Information Services Division, and co-investigators who held CSO-funded grant on prisoners' mortality: analysis of impact of Scotland's in-prison methadone programme on drugs-related deaths soon after release (paper in preparation).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry, Psychology &amp; Neuroscience</gtr:department><gtr:description>Impact of opiate substitution treatment on drug related deaths in the population</gtr:description><gtr:id>F0C334F4-E425-49E6-B63D-709B4D2BAE64</gtr:id><gtr:impact>Outline Research Proposal to NIHR Health Services and Delivery Programme</gtr:impact><gtr:outcomeId>hQaKbDk7sbx-2</gtr:outcomeId><gtr:partnerContribution>Research methodology &amp;amp; datasets, PPI</gtr:partnerContribution><gtr:piContribution>Research methodology &amp;amp; datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Glasgow Caledonian University (GCU)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Public Health and Epidemiology</gtr:department><gtr:description>Bayesian capture-recapture analysis of current injectors in England, 2009</gtr:description><gtr:id>9B6DA35E-4ED8-42C3-A21C-F57CAE02CB1E</gtr:id><gtr:impact>See publications list</gtr:impact><gtr:outcomeId>BNsGSrwYXd3-2</gtr:outcomeId><gtr:partnerContribution>As above - joint development of methods and ideas.</gtr:partnerContribution><gtr:piContribution>We have been developing Bayesian capture-recapture methods to allow for different capture-propensities across English regions and to make comparison between estimates from 2005 (already published) and 2009 (in preparation)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Crime Reduction Initiatives (CRI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Research Collaboration Agreement with CRI</gtr:description><gtr:id>B6C736B9-69DC-4373-A07F-92036EF9E6A8</gtr:id><gtr:impact>CRI/University of Manchester conference &amp;quot;Recovery and Beyond&amp;quot; Manchester, 5th September 2012</gtr:impact><gtr:outcomeId>e6FMJmncjEV-1</gtr:outcomeId><gtr:partnerContribution>CRI brings clinical expertise and the largest addiction patient cohort (circa 25k) in the UK, together with clinical information systems and IT infrastructure capable of supporting e-health research. 

CRI is now the addiction treatment service provider in recruitment areas for the ICCAM MRC Addiction Research Cluster Platform Study, in which the University of Manchester is a partner, and the collaboration will help to facilitate patient recruitment for this MRC study.</gtr:partnerContribution><gtr:piContribution>The University of Manchester (Millar) has entered a research collaboration agreement with CRI, the largest provider of addiction treatment in the UK, as a platform for collaborative translational research, including potential future work by the NIQUAD MRC Addiction Research Cluster.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Mathematics and Statistics St Andrews</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>86C704AC-0A5F-4DAF-A1CC-579D5E1E87B8</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-4</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry, Psychology &amp; Neuroscience</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>2531E261-2847-4D12-8421-6399AF642570</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-5</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Community Medicine</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>9C05CAC9-0B07-451C-9149-5D1521103E60</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Health and Social Impact on Children Who Experience Serious Parental Alcohol Misuse</gtr:description><gtr:id>F2DB2879-14BB-48C7-8934-1FEDB0DCC9C6</gtr:id><gtr:impact>Grant application submitted, unsuccessful.</gtr:impact><gtr:outcomeId>5458d8b441c180.76853675-1</gtr:outcomeId><gtr:partnerContribution>Expertise in the analysis of linked Scandinavian datasets &amp;amp; in alcohol research</gtr:partnerContribution><gtr:piContribution>Expertise in the analysis of linked secondary datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Methadone prescribing in Scotland</gtr:description><gtr:id>A31BB804-7A2F-4F3C-B2C4-F8A0168D15DF</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>FG8BsEmWRyM-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>Bird, with Prof Marion Bennie on methadone prescribing in Scotland</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS National Services Scotland (NSS)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Protection Scotland</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>E5096EA5-DA5E-4784-81DD-54214EE049D0</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-8</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Information Services Division (ISD)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIQUAD</gtr:description><gtr:id>490EB8A4-9463-4FAF-BB7C-1DDE51AB606B</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-9</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Impact of opiate substitution treatment on drug related deaths in the population</gtr:description><gtr:id>1E424131-278C-402A-BB7C-015875436FFD</gtr:id><gtr:impact>Outline Research Proposal to NIHR Health Services and Delivery Programme</gtr:impact><gtr:outcomeId>hQaKbDk7sbx-1</gtr:outcomeId><gtr:partnerContribution>Research methodology &amp;amp; datasets, PPI</gtr:partnerContribution><gtr:piContribution>Research methodology &amp;amp; datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ministry of Justice</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIQUAD</gtr:description><gtr:id>E3EF1339-C654-4865-A5DE-F4F55F66FC7F</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-10</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Community Medicine</gtr:department><gtr:description>Natural history of drug use and offending</gtr:description><gtr:id>C20C151E-DF0C-4773-B898-B7F93FF92175</gtr:id><gtr:impact>MRC Research Grant application</gtr:impact><gtr:outcomeId>fHzBqi8UThp-2</gtr:outcomeId><gtr:partnerContribution>Methodological approaches to drug use epidemiologyMethodological approaches to drug use epidemiology</gtr:partnerContribution><gtr:piContribution>Research proposal</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Political Sciences Glasgow</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>ED35AA5F-7CA6-4D38-A333-E4CE2E2335A5</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-11</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>Natural history of drug use and offending</gtr:description><gtr:id>52892928-E94A-46ED-8711-3DDF63AC9B26</gtr:id><gtr:impact>MRC Research Grant application</gtr:impact><gtr:outcomeId>fHzBqi8UThp-1</gtr:outcomeId><gtr:partnerContribution>Methodological approaches to drug use epidemiologyMethodological approaches to drug use epidemiology</gtr:partnerContribution><gtr:piContribution>Research proposal</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Health Sciences</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>ECD8D710-61C1-4A2D-B8EE-A1B3EA6555E7</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-3</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Mathematics and Statistics</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>983FEB0B-34CA-4BA6-8E66-F0646F015BB9</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-6</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Mathematics and Statistics St Andrews</gtr:department><gtr:description>Bayesian capture-recapture analysis of current injectors in England, 2009</gtr:description><gtr:id>71996646-55FA-4D4A-866F-D62D9B2BE88C</gtr:id><gtr:impact>See publications list</gtr:impact><gtr:outcomeId>BNsGSrwYXd3-1</gtr:outcomeId><gtr:partnerContribution>As above - joint development of methods and ideas.</gtr:partnerContribution><gtr:piContribution>We have been developing Bayesian capture-recapture methods to allow for different capture-propensities across English regions and to make comparison between estimates from 2005 (already published) and 2009 (in preparation)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIQUAD</gtr:description><gtr:id>F91B21E0-B5E9-46A5-AB75-0939BAE5E8FE</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-7</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Community-Based Medicine</gtr:department><gtr:description>NIQUAD</gtr:description><gtr:id>1EA44CF5-65B7-4968-BB22-99A1A0145D41</gtr:id><gtr:impact>Several publications in press and in preparation, notably 
i) on cause-specific mortality of opiate users in England {Pierce M, BIRD SM, Hickman M, Millar T. National record-linkage study of mortality for a large cohort of opiate users ascertained by drug treatment or criminal justice sources, 2005-2009. Drug and Alcohol Dependence, 2014: in press.}

ii) on impact of treatment modality on drugs-related deaths and of criminal-justice referral into treatment. 

See publications list</gtr:impact><gtr:outcomeId>habDB2swzrs-2</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual contributionIntellectual/ Practical contributionIntellectual/ Practical contributionPractical collaborationPractical collaborationIntellectual/ Practical contribution</gtr:partnerContribution><gtr:piContribution>Two BSU staff members co-grant holders for NIQUAD whose objective is to enable key public health questions about addiction to be addressed by:
- Improving, integrating, and harmonising the information base
- Assessing the quality, precision, validity and consistency of available information
- Making data accessible to a wider range of expertise
- Developing methods to better exploit existing and new information sources

This requires parallel work on developing micro (record linkage) and macro (evidence synthesis) integration of available information. The former strand will integrate administrative and research data at the individual case level to create statistically powerful 'virtual' cohorts that track pathways in and out of treatment, criminal justice, and healthcare, sequencing key events. Evidence synthesis will develop models that link all the available evidence to link and test its consistency and to examine the relationships between parameters.

NIQUAD includes: key experts in surveillance and substance use epidemiology; non-addiction scientists with high-level skills in relevant statistical, mathematical modelling and health economic techniques; and health informatics experts to support the development of data resources to fuel the planned work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Alliance</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Impact of opiate substitution treatment on drug related deaths in the population</gtr:description><gtr:id>3AE34B24-3EE5-43FC-B64D-5E3B903B4A68</gtr:id><gtr:impact>Outline Research Proposal to NIHR Health Services and Delivery Programme</gtr:impact><gtr:outcomeId>hQaKbDk7sbx-4</gtr:outcomeId><gtr:partnerContribution>Research methodology &amp;amp; datasets, PPI</gtr:partnerContribution><gtr:piContribution>Research methodology &amp;amp; datasets</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Addictions Department</gtr:department><gtr:description>Annual OD4-methadone index</gtr:description><gtr:id>711754BC-DDEB-4E77-A1D2-B2AA15A2ED28</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>J68cwUG8uu1-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>Bird, with Prof J Strang, to update and expand Annual OD4-methadone index (number of deaths with methadone implicated per million defined daily doses of methadone prescribed in that year).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Open University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Impact of opiate substitution treatment on drug related deaths in the population</gtr:description><gtr:id>74B398E3-46E5-488B-B8A1-B6C129D66A22</gtr:id><gtr:impact>Outline Research Proposal to NIHR Health Services and Delivery Programme</gtr:impact><gtr:outcomeId>hQaKbDk7sbx-3</gtr:outcomeId><gtr:partnerContribution>Research methodology &amp;amp; datasets, PPI</gtr:partnerContribution><gtr:piContribution>Research methodology &amp;amp; datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>King, Bird, Overstall - Meeting with Scottish Information Service Division</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>06B7D4CE-FE3D-4432-B4CB-A920B1299592</gtr:id><gtr:impact>King, Ruth; Bird, Sheila; and Overstall, Antony: meeting with ISD to to discuss estimates of injecting drug users in Scotland.

-</gtr:impact><gtr:outcomeId>bEQpZ9GtYL8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal United Services Institute, London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30ABE12D-CE6E-4B04-AB6B-EEA98D5143CF</gtr:id><gtr:impact>Millar presented findings on heroin use incidence/prevalence to an audience of policy makers, law enforcement, border force and intelligence officials.</gtr:impact><gtr:outcomeId>56d8384091adf9.97085211</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Statistical Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A52B8A99-6CB4-4F18-A048-3EE9145C617D</gtr:id><gtr:impact>Bird presented on 'Experimental vs Observational Methods to determine the effectiveness of naloxone distribution for determining opiate overdose deaths'.
at RSS Edinburgh &amp;amp; at RSS Lancaster (Nov 21 2013)

-</gtr:impact><gtr:outcomeId>fL8Ah2pkVgV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Entry of 'Elevator pitch' competition at 'early career methodologists' MRC/NIHR event (September 2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>329B4552-01C5-466C-9503-2AB8F269D00A</gtr:id><gtr:impact>Dr Hayley Jones took the opportunity to 'pitch' her methodological research in a strict 4 minute time period. Around 100 academics and NHS researchers were present at this London meeting.

This was an opportunity to explain why the most commonly used method for estimating the size of drug-using populations is flawed - and to suggest what might be done instead - in an accessible and engaging manner.</gtr:impact><gtr:outcomeId>542d5e73ad7fd9.01237107</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.nihr.ac.uk/funding/nihr-and-mrc-symposium-for-early-career-research-methodologists.htm</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sewage Epidemiology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B383D4EB-E4A8-43F1-95C7-AB6DC26C5A54</gtr:id><gtr:impact>Jones presented 'Accounting for uncertainties in sewage epidemiology' at The first international multidisciplinary conference on detecting illicit drugs in wastewater, EMCDDA, Lisbon, Portugal. May 2013

-</gtr:impact><gtr:outcomeId>sryX2NhwL7g</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scotland - National Naloxone Advisory Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93239368-C2CB-4F48-8501-255A93EC09EE</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>iQZx4uZdXHK</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Drugs-related deaths: by demography and toxicology and per 1,000 users Bird, invited lecture in Melbourne, Australia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>025FB7D9-D2EE-42ED-B3FA-1A3F0EE6E006</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5462071da5fc64.30182223</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Group on Estimating the Prevalence of Substance Misuse in Scotland</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87E91E09-6B63-41D1-85E0-FAF7184D50B3</gtr:id><gtr:impact>Hutchinson &amp;amp; Hickman - Advisory Group for a Scottish Government funded project, coordinated by the Information Services Division of NHS Scotland, involving policymakers and practitioners.

Provided a steer that further modelling work was needed on estimating prevalence of injecting drug use in Scotland. This is work that is being followed up now by King, Bird &amp;amp; Overstall.</gtr:impact><gtr:outcomeId>Q6F3BCTG27S</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DrugScope 'Blog' of results of mortality work</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF87AE39-B03E-4BEC-8AAB-9324258B73B9</gtr:id><gtr:impact>DrugScope produced a 'Blog' summarising our work on opioid user mortality. This received &amp;gt;1700 views in the first two weeks of its posting.</gtr:impact><gtr:outcomeId>56e0303f18dfc0.82341068</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://drugscope.blogspot.co.uk/2015/01/half-picture-beyond-drug-overdose-as.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented new methods and results to policy makers from Public Health England and the Home Office - September 2015 at PHE</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF8E07EB-4677-40FE-8E23-6D2B57BDB93F</gtr:id><gtr:impact>Jones &amp;amp; Hickman presented new estimation methods and results to policy makers from Public Health England and the Home Office - September 2015, at PHE.</gtr:impact><gtr:outcomeId>56d8374c18b569.45887453</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Estimating the prevalence of problem drug use: the pitfalls of capture-recapture estimation and proposal for more coherent modelling' Seminar at the Center for Evidence Synthesis in Health, School of Public Health, Brown University, USA. 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3DFF51F6-1BFB-47FD-9BD6-2B39C2099255</gtr:id><gtr:impact>Jones presented at seminar by invitation</gtr:impact><gtr:outcomeId>58c13aa01bd280.69573066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Statistical Society lead on need for legislation to end late registration of deaths in E and W</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8442A14F-98F3-4829-8378-9614C3277E96</gtr:id><gtr:impact>Audience of 150 at Royal Society included Science Minister David Willetts whose attention I thereby drew to the delays in registration of inquest-deaths.

Conference @ RS was entitled: Foundation debate on maximising the use made of public and research data - 10Jul13

2014 Open Letter to Prime Minister (with Sense about Science and six Charities including INQUEST, SAMARITANS) to press for legislation in the current parliament. Request declined by Simon Hughes on behalf of government but he did engage in a helpful correspondence. Support also from PQs by Dr Julian Huppert , Cambridge MP.

The report by Professor David Wilkie CBE on the Foundation round-table discussion and debate on the theme &amp;quot;Maximising the use of public data - should research and publically acquired data be made more accessible&amp;quot; has now been posted on the Foundation web site together with the speakers presentations where available and audio files of what they said. 

The speakers were Professor Geoffrey Boulton OBE FRS FRSE, Chair, The Royal Society Inquiry into Science as an Open Enterprise, Professor Sir Nigel Shadbolt FREng, Chairman and Co-Founder of the Open Data Institute, The Rt Hon David Willetts MP, Minister of State for Universities and Science, Department for Business, Innovation and Skills. Professor Sheila M Bird OBE FRSE, Programme Leader, MRC Biostatistics Unit, Institute of Public Health, Cambridge, joined the panel in the discussion sessions.

The Foundation site is at:

www.foundation.org.uk

The round-table discussion was held at The Open Data Institute and the debate was held at The Royal Society.</gtr:impact><gtr:outcomeId>h36dVDLKNaz</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.rss.org.uk/uploadedfiles/userfiles/files/18%20June%202014%20Open%20Letter%20to%20PM%20Late%20Registration%20of%20the%20dead.pdf</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Informatics Program Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>70F9788B-FFED-44E2-80FF-A943C95E8959</gtr:id><gtr:impact>Bird contributed lectures at SHIP conference in St Andrews in August 2013.

-</gtr:impact><gtr:outcomeId>ZnifCuN2bjT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>College on Problems of Drug Dependence</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F5BADE1F-7418-4381-8AEF-1C07E409762F</gtr:id><gtr:impact>Bird presented on 'Experimental vs Observational Methods to determine the effectiveness of naloxone distribution for determining opiate overdose deaths'.
at Naloxone Workshop at June 2013 conference in San Diego, USA of the College on Problems of Drug Dependence

-</gtr:impact><gtr:outcomeId>orZYJEfu9mT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Estimating the prevalence of problem drug use: the pitfalls of capture-recapture estimation and proposal for more coherent modelling' Seminar at the Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK. 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C770DA3D-98C9-4639-A3D5-B10C4B4D1500</gtr:id><gtr:impact>Jones presented at seminar by invitation</gtr:impact><gtr:outcomeId>58c13a682e3293.83549445</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EASL Amsterdam</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A4171506-2711-49FF-8C2E-43D124AE555C</gtr:id><gtr:impact>Hickman presented &amp;quot;Primary prevention of Hepatitis C&amp;quot; at the 48th Annual Meeting of the European Association for the study of the liver, 2013, Amsterdam

-</gtr:impact><gtr:outcomeId>Tm9BnmdZbgU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hickman, Jones, Marsden, Pierce, Millar - Meeting with Home Office, Department of Health and national Treatment Agency for Substance Misuse</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>618B228E-E4FF-4E5F-919C-7FD671778758</gtr:id><gtr:impact>Hickman, Matthew; Jones, Hayley; Marsden, John; Pierce, Matthias; Millar, Tim: Meeting with Home Office, Department of Health, and National Treatment Agency for Substance Misuse to discuss findings in respect of prevalence estimation methodology and their implications for national estimates of the prevalence of opiate and/or crack cocaine use.

-</gtr:impact><gtr:outcomeId>jh6BQYkXVJQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Focal Point on Drugs - invited presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4CA9AA98-BCA2-4CE7-A04D-A403F1278FA6</gtr:id><gtr:impact>Representatives of govt Science, policy, and researchers/experts, and EU representative attended expert meeting on drug related deaths.

Led to invitation to present findings at EU /EMCDDA Annual Meeting on Drug Related Deaths</gtr:impact><gtr:outcomeId>EzQM5Hj7qCB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Monitoring Centre on Drugs &amp; Drug Addiction, Lisbon, invited presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53368E62-12E7-42AB-A628-9381A8273245</gtr:id><gtr:impact>Representatives of EU Member states attended an invited presentation as part of the EMCDDA Annual Expert Meeting on Drug Related Deaths. &amp;quot;Record-linkage study of cause-specific mortality for 219,000 opiate or crack-cocaine users ascertained by drug treatment or criminal justice records in England and Wales, 2005-2009.&amp;quot; Pierce, Bird, Hickman, Millar (presented), 17th October, Lisbon.

We received very positive feedback for our work on drug user mortality in England and Wales, which is at the forefront of EU research activity in this area, and were invited to contribute to EMCDDA synthesis work.</gtr:impact><gtr:outcomeId>rcZJqigiz8C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Statistical Society - legislation to end the late registration of deaths in E&amp;W</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>03FDB807-8EB3-4FBA-AA27-A73BD7090969</gtr:id><gtr:impact>Bird leads on this activity for RSS.

-</gtr:impact><gtr:outcomeId>ZGB2zCfxF2m</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ONS Seminar - drug user mortality</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2C5A0F9B-C5C5-43CA-A67B-95EA3E371422</gtr:id><gtr:impact>ONS statisticians from the Life Events and Population (formerly Health &amp;amp; Life Events) Division at Office for National Statistics, Newport attended a presentation of findings re drug user mortality.

-</gtr:impact><gtr:outcomeId>cBrx8B91gAt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre for Addiction Research &amp; Education, Scotland, conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3DEDB310-905E-45F4-979D-693FCA1A6D36</gtr:id><gtr:impact>Bird presented on 'Do pharmaceutical interventions reduce drugs-related deaths? ' at 12th CARES [Centre for Addiction Research &amp;amp; Education, Scotland] conference on 7 June 2013, University of Dundee

-</gtr:impact><gtr:outcomeId>Voo7EqBHXkk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISCB conference, Munich (August 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2AB7971B-5053-40DE-876A-FCDD9E9700FE</gtr:id><gtr:impact>Around 30-40 academics attended a presentation on statistical methodology for estimating the size of drug-using populations, at the International Society for Clinical Biostatistics (ISCB) annual meeting. This talk highlighted important flaws that we had identified with the most commonly used methodology.

The talk clearly stimulated interest in the work, with several questions asked and more people coming to discuss the work later.</gtr:impact><gtr:outcomeId>542d57d3569b18.68235380</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.iscb2013.info/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Home Office, Public Health England, meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8FCB18EF-9931-4F6F-AC98-3361A7C2C6AE</gtr:id><gtr:impact>Met with Home Office Science (Crime and Policing, Drugs and Alcohol) and Public Health England colleagues to discuss evidence synthesis for drugs, crime and mortality.

-</gtr:impact><gtr:outcomeId>VY2HLmiqdnB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>King, Ruth - January 2012: Invited seminar at the National Records of Scotland (formerly the General Register Office for Scotland) (Edinburgh).</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7663B39E-46C7-4881-A249-910779FF0E3E</gtr:id><gtr:impact>-

Following the seminar at National Records Scotland (NRS) King &amp;amp; Overstall have been invited to undertake a feasability study for extending the standard log-linear models to allow forcorrupted records, partial data collation and observation of non-target individuals.</gtr:impact><gtr:outcomeId>aedTmKDmXY2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Drugs-related Deaths in Glasgow  Bird, invited lecture to  Scotland's National Forum on Drugs-related Deaths</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C8BB3D9-9B2B-4EDF-BF2E-25656132CD08</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54620795378f58.59240156</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Government (Justice Department, Drug Policy Unit)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B769706-894D-445B-8FA1-95EC862A4B10</gtr:id><gtr:impact>Seminar on 'The case for RCTs in Criminal Justice'.
Since mid 2010 SMB has been member of Scotland's National Naloxone Advisory Group, which monitors the impact of Scotland's public health policy on take-home naloxone (implemented from January 2011)

Second invitation which arose out of a previous seminar on related material. 
SMB provided scientific background and study size considerations for Scotland's before-after comparison of percentage of opiate-related deaths that occur within 4 weeks of release from prison. This is a key outcome measure in monitoring the impact of take-home naloxone.
SMB also arranged for 3 naloxone related questions to be added to Scotland's Needle Exchange Surveillance of Injectors (NESI) in 2011 to assist in monitoring the carriage of naloxone.</gtr:impact><gtr:outcomeId>8623E55C79E</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ruth King - Invited speaker at the London Mathematical Society 150th Popular Lectures, 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>35A8CCDC-D4EC-4535-8A4D-97E92ABC7F2E</gtr:id><gtr:impact>King Presented at a public lecture on estimation methods, also available to the public via YouTube</gtr:impact><gtr:outcomeId>58c13fa6002a53.70931883</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=_BCM8Fg7Nb4</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Cooks Tour of Drug Misuse Epidemiology: Millar, lecture to GP Clinical Commissioning Leads, November 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C5367F1D-BD33-4F84-B2A0-C6F780ACCBCB</gtr:id><gtr:impact>Lecture described extent and causes of death among opiate users, extent of crime, and treatment effects thereon. Audience comprised GPs responsible for clinical commissioning as part of a DH-funded training scheme.

-</gtr:impact><gtr:outcomeId>5462088dca81a3.82671376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mortality and treatment among 200,000 opioid users in England, 2005-2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F55D6AF4-56D9-4961-B890-1D8F69ED147D</gtr:id><gtr:impact>Pierce presented findings to the CRI/University of Manchester National Clinical Conference, June, 2014

The presentation prompted considerable debate</gtr:impact><gtr:outcomeId>54622058c67fa4.17912020</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited presentation to the joint annual meeting of the Manchester Medical Society and Liverpool Medical Institution, Liverpool, March 6th 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A3E3DB0D-4AB8-4FDB-8FBC-4ABD011C83F4</gtr:id><gtr:impact>Presented findings regarding drug user mortality to audience of clinicians.

Resulted in further invitations to present this material to clinical groups.</gtr:impact><gtr:outcomeId>5458cc4c620cb7.28730493</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Expert Group convened by PHE and Collective Voice to identify best practice in reducing drug related deaths</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7CB7C5F5-B9C2-4C52-AEB5-EBDECA92570B</gtr:id><gtr:impact>Expert group representing Third Sector and NHS providers of substance misuse treatment to identify best practice in reducing drug related deaths</gtr:impact><gtr:outcomeId>58b59512565ad9.61816382</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Manchester Addiction Research Network - presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>069F32D2-A026-4C34-A9B0-BA0BD3B3696E</gtr:id><gtr:impact>Local researchers &amp;amp; health commissioners attended a presentation.

Public Health England (G Mcr) invited a further presentation for a commissioner conference next year, to coincide with publication of main findings.</gtr:impact><gtr:outcomeId>c6yKzVXk5wK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Health England, Greater Manchester base</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8C9B37BB-2AAB-4D22-9361-F3EE3210357A</gtr:id><gtr:impact>Presented findings re drug user mortality to PHE colleagues.

-</gtr:impact><gtr:outcomeId>s6C8QcgqYDx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sewage Epidemiology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E0B35F40-349E-43D3-80B2-6D29C52338C7</gtr:id><gtr:impact>Hickman presented 'Key challenges for integrating wastewater data into the epidemiology models: why do we need to... where do we go next? at the First international multidisciplinary conference on detecting illicit drugs in wastewater, EMCDDA, Lisbon, Portugal. May 2013

-</gtr:impact><gtr:outcomeId>GUg7uWKFWys</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>M Hickman: Invited Expert NIDA Expert Meeting on Drug Related Mortality. Symposium on Modelling. CPDD Miami June 2011</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60CF8A77-893B-465F-9D6D-3FA35748CA56</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>nHgusyGaiMo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Millar, speaker at EMCDDA Continuity and Change, 23-26 September 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF36D3C5-FDC9-4662-80EA-0590B0545A06</gtr:id><gtr:impact>Presented findings on drug user mortality to audience of EU member state representatives.

-</gtr:impact><gtr:outcomeId>5458cb7c99a064.27912364</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Presentation to Public Health England staff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47A78279-E5FE-44C5-8BE3-8462F503EB88</gtr:id><gtr:impact>PHE Regional Staff attended a one day seminar where Millar presented findings on drug user mortality &amp;quot;Plugging the knowledge gap with Research - Analysis of secondary datasets better to understand drug user mortality&amp;quot;

-</gtr:impact><gtr:outcomeId>5458cddad5a313.79294294</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>M Hickman: Invited expert - Primary prevention of HCV. South West Hepatology Group. Bristol November 2011</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F770EA4A-6AC8-4CE4-A300-D16BE05A6763</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>pzmVWr9rjdk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Network on Hepatitis in Substance Users</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9ADE5BF-B9F6-46A9-9ED5-28027240D461</gtr:id><gtr:impact>Hickman presented at the The 3rd International Symposium on Hepatitis Care in Substance Users, 2013, Munich

-</gtr:impact><gtr:outcomeId>RxLuiBczB16</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Driving Innovation and Delivering Excellence</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>69FAC532-1128-4B74-BC72-7A10DDED6208</gtr:id><gtr:impact>Millar co-Chaired the CRI/University of Manchester national clinical conference, June 2014

-</gtr:impact><gtr:outcomeId>54620a6561b2b8.15745117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cri.org.uk/clinical_conference</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SCORE COST Working group meeting in Malta, October 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A0CCE6D-2693-4814-8EEF-4C409AAECFC9</gtr:id><gtr:impact>Jones &amp;amp; Hickman presented &amp;quot;Integration of wastewater data with epidemiology: Statistical considerations relating to uncertainties&amp;quot;

-</gtr:impact><gtr:outcomeId>5458dc21b1d3b5.85366071</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Drug related mortality, treatment and recovery - NTA/PHE Recovery Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5995B274-B943-49D4-A280-DDAAA50F2F34</gtr:id><gtr:impact>Hickman presented evidence to NTA/PHE Recovery Group

-</gtr:impact><gtr:outcomeId>X5j2Lyonw5v</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Statistical Society Seminar - Causes of Mortality (Manchester, October 2016)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E607D91-2A53-44CD-A1C3-08A928BD9DBC</gtr:id><gtr:impact>Millar presented work on premature mortality among opioid users to the RSS seminar</gtr:impact><gtr:outcomeId>58b59ba5bf1621.15327338</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Group for Scottish Government regarding the formula for NHS funding distribution for Sexual Health &amp; Blood Borne Viruses</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3C1D292F-5A87-4B6A-853F-F798C0C35C26</gtr:id><gtr:impact>Hutchinson - The research and outputs from NIQUAD will inform this advisory group.

-</gtr:impact><gtr:outcomeId>VKWVKWdiPki</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National expert working group to investigate drug-related deaths in England</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>62CAEB4E-8BF4-4E5F-8083-E065432CCA77</gtr:id><gtr:impact>Millar &amp;amp; Hickman contributed to the PHE national inquiry, in partnership with the Local Government Association, to investigate the causes of the rise in drug related deaths and what could be done to prevent future premature deaths.</gtr:impact><gtr:outcomeId>58b59436a13bc7.64616634</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.nta.nhs.uk/uploads/phe-understanding-preventing-drds.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>M Hickman: Invited expert - Drug related mortality epidemiology. Vedette Cohort Study. Turin April 2011</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B182377A-329E-4BB4-86E5-9D36A30CBE7F</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>ttZnfyAiRUN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>M Hickman: Invited expert - Hepatitis Epidemiology and Prevention. Liver Meeting. Hospital Doctor. London June 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>10325667-9FB3-4795-A42E-E8DA42D73248</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>rMPUKL48eEE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - Abi Lindon (Bristol) Comparison of the protection afforded by methadone and buprenorphine maintenance to heroin/morphine relapse and the effect of ethanol on any protection.</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C14965B8-6FED-4B93-A1E0-0D5A728BA92A</gtr:id><gtr:outcomeId>nVPaNnPDSjN</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1130886</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Department of Health Policy Research Programme</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:id>C8EC5012-6E3E-4E11-B019-4036C65BE405</gtr:id><gtr:outcomeId>CJ2HjEqsitB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4373292</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council: E-Health Research Initiative</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E8756C1D-A421-4DDF-B493-DBF1BE0C41CB</gtr:id><gtr:outcomeId>ebSkg4V7ajU</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institute for Health Research HS&amp;amp;DR Programme</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>40E0E30C-0FF9-4BB5-89C9-29BAC8B76254</gtr:id><gtr:outcomeId>fzo7N7zZvfx</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>375101</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Career Development Awared in Biostatistics (fellowship)</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9B3E2BAC-23E8-4327-9E71-F47CE123DB24</gtr:id><gtr:outcomeId>56cdcbafcb0378.66861580</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Research Council Starting Grant</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>5DA6330A-79F5-4E7F-9C90-C556B092EAFB</gtr:id><gtr:outcomeId>5458c8710330b2.72101656</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Wastewater analysis of traces of illicit drug-related chemicals for law enforcement and public health (WATCH)</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>F45BC8AB-F32F-4B99-91C7-104ED3E841E0</gtr:id><gtr:outcomeId>58c1403d393855.02992081</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>282000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institute for Health Research, Public Health Research Programme</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>BF2C2079-D4AF-482E-A557-BEC073640AF8</gtr:id><gtr:outcomeId>b6sA7G1LURA</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11000</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>n/a</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>European Monitoring Centre for Drugs and Drug Addiction</gtr:fundingOrg><gtr:id>898033B3-10E9-4CAD-9A6C-7C81E884232E</gtr:id><gtr:outcomeId>58b59a7e23bda6.95691731</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;Understanding and preventing drug-related deaths The report of a national expert working group to investigate drug-related deaths in England&amp;quot; (Public Health England, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>34B01180-9320-40B5-B862-F936CE325BAA</gtr:id><gtr:outcomeId>58b597a158dd58.59099133</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.nta.nhs.uk/uploads/phe-understanding-preventing-drds.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;Understanding and preventing drug-related deaths The report of a national expert working group to investigate drug-related deaths in England&amp;quot; (Public Health England, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D4F6C169-CC88-4A78-81D3-6E80BB3AFBC6</gtr:id><gtr:outcomeId>58b598bbf0b573.84298528</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.nta.nhs.uk/uploads/phe-understanding-preventing-drds.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users?&amp;quot; (Advisory Council on the Misuse of Drugs, 2015)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>21F80486-579B-4360-8FDB-D83DE9EA34CB</gtr:id><gtr:outcomeId>58b59d6ce884c7.04045945</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470399/ACMD_RC_OPTIMISING_OST_REPORT_231015.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in&amp;quot;Understanding and preventing drug-related deaths The report of a national expert working group to investigate drug-related deaths in England&amp;quot; (Public Health England, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C11BF11-3D0E-466D-A005-9909DF4B2E7D</gtr:id><gtr:outcomeId>58b5972f191331.26288786</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.nta.nhs.uk/uploads/phe-understanding-preventing-drds.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Risk assessment for overdose and suicide among treated opioid users</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C5E1388F-3554-4019-A0BB-36951B203151</gtr:id><gtr:impact>Findings from our work on drug user mortality have informed the development of routine 'risk scoring' of patients treated by a large UK addiction treatment provider (circa 40,000 patients) to highlight those most likely to be at risk of fatal overdose or suicide.</gtr:impact><gtr:outcomeId>56d8359dc27ba2.97268196</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Use of Bayesian estimation methods to estimate prevalence of problem drug use in Wales</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>DC323326-211C-4AFC-928A-584A29F45B59</gtr:id><gtr:outcomeId>56d836bd818b54.23566949</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://gov.wales/docs/dhss/publications/160104substanceannualen.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users?&amp;quot; (Advisory Council on the Misuse of Drugs, 2015)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BBC18CEC-D71B-439A-BADF-83462C8C1766</gtr:id><gtr:outcomeId>58b59d0b921a42.13772343</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470399/ACMD_RC_OPTIMISING_OST_REPORT_231015.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bird, Sheila: Scotland's National Naloxone Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D6DF96F2-42DB-46B3-A6A3-61CF0D4E317C</gtr:id><gtr:outcomeId>MZkrNtJVQNo</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bird, Sheila: Home Affairs Select Committee's seminar on drugs policy.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>621AF1FD-2095-456C-BB0B-CDADCB608F8F</gtr:id><gtr:outcomeId>DJPFGB8J169</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bayesian capture-recapture approaches used by Public Health Wales</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7F0B7DB5-9316-4A23-84D5-69018B0CC56C</gtr:id><gtr:impact>Knowledge of the size of the 'in need' population</gtr:impact><gtr:outcomeId>58c13df1f09bd0.77103548</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www2.nphs.wales.nhs.uk:8080/SubstanceMisuseDocs.nsf/5633c1d141208e8880256f2a004937d1/9033e325fd64e85980257eed0031a86a/$FILE/Reading_between_the_lines_Annual_Profile_Substance_Misuse_Wales_2014-15.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Enhancing clinical audit of drug user mortality in a large UK addiction treatment provider</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>802ACBDE-50C3-40B9-A582-5B43C11CE3EE</gtr:id><gtr:outcomeId>hqZb9CTzFuw</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;Reducing Opioid-Related Deaths in the UK&amp;quot; (Advisory Council on the Misuse of Drugs, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C207B8E2-17E3-4ED6-860A-48977F0AB236</gtr:id><gtr:outcomeId>58b5992a0fce68.54837448</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/576560/ACMD-Drug-Related-Deaths-Report-161212.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;Reducing Opioid-Related Deaths in the UK&amp;quot; (Advisory Council on the Misuse of Drugs, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E72EEB27-ED89-4C97-BD2B-A1B42AD0F071</gtr:id><gtr:outcomeId>58b599bf2603b0.89276873</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/576560/ACMD-Drug-Related-Deaths-Report-161212.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in &amp;quot;Reducing Opioid-Related Deaths in the UK&amp;quot; (Advisory Council on the Misuse of Drugs, 2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>541E04FA-82FD-4017-950D-BEA16A33FECD</gtr:id><gtr:outcomeId>58b59971136ac3.80545406</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/576560/ACMD-Drug-Related-Deaths-Report-161212.pdf</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Overstall has developed an R package to implement Bayesian model-averaging for contingency table log-linear models (with or without missing cell entries). An associated paper will be submitted.</gtr:description><gtr:id>1F1488F8-CF3D-409A-9E08-91CBB07CCE34</gtr:id><gtr:impact>Publication</gtr:impact><gtr:outcomeId>efL6CHM1FY2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bayesian Model averaging tool</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Linkage of an existing database about substance misusers contacts with health /criminal justice with ONS records relating to mortality.</gtr:description><gtr:id>E72D96AA-90E3-46B7-8BFC-734ECE62FE64</gtr:id><gtr:impact>This will enable work to investigate drug user mortality and intervention impacts.</gtr:impact><gtr:outcomeId>qhwwDdJNhZH</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Drug Data Warehouse mortality linkage</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>23A7CC2E-0C32-4A59-884F-617141A1C0AC</gtr:id><gtr:title>Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/211faca1e27d75be4894fa9634596cee"><gtr:id>211faca1e27d75be4894fa9634596cee</gtr:id><gtr:otherNames>Palmateer NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>doi_15241_012_08_006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5135E391-03FA-458B-AFB6-C75F0AC177A3</gtr:id><gtr:title>A cross-sectional study of emergency department visits by people who inject drugs.</gtr:title><gtr:parentPublicationTitle>Emergency medicine journal : EMJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d049b1ce9586743fc63f62478f92e414"><gtr:id>d049b1ce9586743fc63f62478f92e414</gtr:id><gtr:otherNames>Aitken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-0205</gtr:issn><gtr:outcomeId>doi_15241_012_201170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0A0EC65-A5A8-4ABC-8B42-505C063FB07A</gtr:id><gtr:title>Mitigating the risk of HIV infection with opioid substitution treatment.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a236c621d068718b7788380b08a0ac9"><gtr:id>6a236c621d068718b7788380b08a0ac9</gtr:id><gtr:otherNames>Gowing LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>doi_15241__12_109553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1BE4E09-8803-4981-B7C9-7E5E25DAC4E8</gtr:id><gtr:title>Registration of deaths in European countries: survey results</gtr:title><gtr:parentPublicationTitle>Straight Statistics (http://www.straightstatistics.org/article/registration-deaths-european-countries-survey-results)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>p2S5uXUN57B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A9B8AF6-FD5B-476F-BDEF-777EAB299785</gtr:id><gtr:title>Estimating prevalence of injecting drug users and associated heroin-related death rates in England by using regional data and incorporating prior information</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0d3cf730dd45838345aed36a7c7886c"><gtr:id>e0d3cf730dd45838345aed36a7c7886c</gtr:id><gtr:otherNames>King R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56cdc8d09ba017.64921472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93ACADDC-35CD-4381-BE85-6EF3E9A66A07</gtr:id><gtr:title>Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73c9b64294fed6660b23aa161ea67993"><gtr:id>73c9b64294fed6660b23aa161ea67993</gtr:id><gtr:otherNames>Hope VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>544d3b75a4fa07.79064565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BBA965C-1CDE-4005-BDF0-7F6392FDA4C5</gtr:id><gtr:title>A systematic review of injecting-related injury and disease among people who inject drugs.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1a4b72a97dc63d32c188d74dd0d458"><gtr:id>6c1a4b72a97dc63d32c188d74dd0d458</gtr:id><gtr:otherNames>Larney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>58c7ae274c2bc5.05450741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84B60486-72DE-4B15-BD22-A4F12CD57B76</gtr:id><gtr:title>Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>pm_15241_21_23453261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF5BB86F-3E53-4B3F-842C-5A7809DA14F7</gtr:id><gtr:title>Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results.</gtr:title><gtr:parentPublicationTitle>Harm reduction journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cdde02c80a9093cd7100e3c905608cc"><gtr:id>6cdde02c80a9093cd7100e3c905608cc</gtr:id><gtr:otherNames>Horyniak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-7517</gtr:issn><gtr:outcomeId>544d3a4c125b89.09557878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E554FBB3-F01D-4071-861D-8035F992562A</gtr:id><gtr:title>Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca638222718c23958ef46c97c75094a"><gtr:id>8ca638222718c23958ef46c97c75094a</gtr:id><gtr:otherNames>Xia Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>56e02dcaab6d78.87959190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C46BB59E-18B5-4FE3-9493-0EA415AA9068</gtr:id><gtr:title>Commentary on Kelty &amp;amp; Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>nbd7qkbEuVF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51BDA156-6DF3-45CF-9265-18857BBEFA8C</gtr:id><gtr:title>Progress in reducing death registration delays, but more is needed.</gtr:title><gtr:parentPublicationTitle>Straight Statistics (http://www.straightstatistics.org/article/progress-reducing-death-registration-delays-more-needed)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>FJgk5E1yRjN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>871117E1-81CD-4629-8AFF-F479864D1F31</gtr:id><gtr:title>A default prior distribution for contingency tables with dependent factor levels.</gtr:title><gtr:parentPublicationTitle>Statistical methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0640257da208e905db9f4ca7f6ca22fb"><gtr:id>0640257da208e905db9f4ca7f6ca22fb</gtr:id><gtr:otherNames>Overstall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1572-3127</gtr:issn><gtr:outcomeId>5458d2dbeaa042.28127300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5734E1A-4CA8-4E93-B0C8-8E61B748D969</gtr:id><gtr:title>Review of methodological issues in cost-effectiveness analyses relating to injecting drug users, and case-study illustrations</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b7e61d06345b9eb87ad0778cad67feb"><gtr:id>0b7e61d06345b9eb87ad0778cad67feb</gtr:id><gtr:otherNames>White S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546206140de5c0.71859954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56CEA8BD-A938-4D52-945F-EE2D4B1A7E2F</gtr:id><gtr:title>Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5458cf72c64e17.99919463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5E26960-70B2-4A9B-80E9-2286A5B172D3</gtr:id><gtr:title>Editorial: Counting the dead properly and promptly</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/456944e90382f98c2f7a04792836902a"><gtr:id>456944e90382f98c2f7a04792836902a</gtr:id><gtr:otherNames>Bird S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>K3ddqowdwgb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42FB1F69-6391-425A-B783-4819128DC939</gtr:id><gtr:title>Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73c9b64294fed6660b23aa161ea67993"><gtr:id>73c9b64294fed6660b23aa161ea67993</gtr:id><gtr:otherNames>Hope VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>544d3b7614a830.33061706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F730D239-451E-4161-B20B-5D2B593116A4</gtr:id><gtr:title>Mortality among people who inject drugs: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d13b549d4bab69c888aed2ffd2862d9"><gtr:id>4d13b549d4bab69c888aed2ffd2862d9</gtr:id><gtr:otherNames>Mathers BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>pm_15241_21_23554523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8035BC57-CAB7-4197-95CC-C64D84B6515F</gtr:id><gtr:title>Could low dead-space syringes really reduce HIV transmission to low levels?</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>doi_15241_012_10_006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E4306C7-F64B-4E29-BEF1-5FB39E5C0AF5</gtr:id><gtr:title>Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4797e3397f62e9136216ecfc151bb8b"><gtr:id>c4797e3397f62e9136216ecfc151bb8b</gtr:id><gtr:otherNames>Marsden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>58c7c786537e16.04066709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDF34998-BA48-4871-95AE-6856CF1090B3</gtr:id><gtr:title>Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1a4b72a97dc63d32c188d74dd0d458"><gtr:id>6c1a4b72a97dc63d32c188d74dd0d458</gtr:id><gtr:otherNames>Larney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>56e02dca29a294.21569230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>981C62A4-39B3-4D4C-8642-AAC438B71E58</gtr:id><gtr:title>&amp;quot;The Drug Data Warehouse: Linking data on drug misusers and drug-misusing offenders&amp;quot; Home Office Research Report 63, London, Home Office</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2faab1aba8f2ad12702ed08520e5fee4"><gtr:id>2faab1aba8f2ad12702ed08520e5fee4</gtr:id><gtr:otherNames>Millar, Tim</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-84987-726-8</gtr:isbn><gtr:outcomeId>oVhzJz8f7Ap</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26F3FE41-3E99-466F-A6FE-B6E2ED3774D5</gtr:id><gtr:title>Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>542d252be70332.12793143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3EA0B93-EAFA-41E1-ABC0-A13873D06E83</gtr:id><gtr:title>Commentary on Mehta et al. (2012): Natural history of injecting drug use.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>pm_15241_21_22248140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>230BA893-D373-49A5-A6EF-528443F61F66</gtr:id><gtr:title>How cost-effective is hepatitis C virus treatment for people who inject drugs?</gtr:title><gtr:parentPublicationTitle>Journal of gastroenterology and hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d582accefa04f804d6bab230d9dd36e"><gtr:id>5d582accefa04f804d6bab230d9dd36e</gtr:id><gtr:otherNames>Martin NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0815-9319</gtr:issn><gtr:outcomeId>doi_15241__jgh_12113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D433BE6-0693-4C41-A36D-3AF5FB1538DF</gtr:id><gtr:title>Peterborough Prison: can matching ride to the rescue of a non-randomized study?</gtr:title><gtr:parentPublicationTitle>Straight Statistics (http://www.straightstatistics.org/article/peterborough-prison-can-matching-ride-rescue-non-randomized-study)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>EjM9PmM1NtB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC2650D5-27DB-4743-ACE0-ECF170F37FE3</gtr:id><gtr:title>Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1a4b72a97dc63d32c188d74dd0d458"><gtr:id>6c1a4b72a97dc63d32c188d74dd0d458</gtr:id><gtr:otherNames>Larney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>5a775cb219eeb2.66870502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDAD173D-67B4-4D6D-8473-7DF3960D10BE</gtr:id><gtr:title>The effectiveness of diversion programmes for offenders using Class A drugs: a systematic review and meta-analysis</gtr:title><gtr:parentPublicationTitle>Drugs: Education, Prevention and Policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc19e9da1a2cc00bf6446099e1f752e1"><gtr:id>cc19e9da1a2cc00bf6446099e1f752e1</gtr:id><gtr:otherNames>Hayhurst K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a775cb23a1189.14373074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31D483E5-5A64-474A-8DB4-A87353ED37B8</gtr:id><gtr:title>Effect of initiating drug treatment on the risk of drug-related poisoning death and acquisitive crime among offending heroin users.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38db94df6d6f87f36e558adffef05d4"><gtr:id>c38db94df6d6f87f36e558adffef05d4</gtr:id><gtr:otherNames>Pierce M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>5a2fd77c969e77.88324121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA2F7A03-942C-48B5-BE21-42FC0096D90E</gtr:id><gtr:title>Commentary on de Vos et al. (2013): can ecological trends in HIV or HCV incidence be used to assess intervention impact?</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>pm_15241_21_23659844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD899DB-6317-4612-A6DB-E36208798946</gtr:id><gtr:title>National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38db94df6d6f87f36e558adffef05d4"><gtr:id>c38db94df6d6f87f36e558adffef05d4</gtr:id><gtr:otherNames>Pierce M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>5458cee0e10b90.65437789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED256FC0-AD58-480A-A11F-953E30E30220</gtr:id><gtr:title>Early life influences on the risk of injecting drug use: case control study based on the Edinburgh Addiction Cohort.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f17a9a58d84211def2f6b3316adb4020"><gtr:id>f17a9a58d84211def2f6b3316adb4020</gtr:id><gtr:otherNames>Macleod J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>doi_13583__add_12056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA46A3DF-2A30-490B-B1DF-039D941DF5B1</gtr:id><gtr:title>Measuring the delays in coroner-certified deaths.</gtr:title><gtr:parentPublicationTitle>Straight Statistics (http://www.straightstatistics.org/article/measuring-delays-coroner-certified-deaths)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>FnugkEz1SsK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5574448-B750-4873-9F6D-F1AE499C5084</gtr:id><gtr:title>Short-Term Outcomes for Opiate and Crack Users Accessing Treatment: The Effects of Criminal Justice Referral and Crack Use.</gtr:title><gtr:parentPublicationTitle>European addiction research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d76303f19265c282fc765d04ce2d33ed"><gtr:id>d76303f19265c282fc765d04ce2d33ed</gtr:id><gtr:otherNames>Jones A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1022-6877</gtr:issn><gtr:outcomeId>56cdc856be5a63.88662633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5D577DB-C474-4435-8156-7C99E6F1DE10</gtr:id><gtr:title>Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2339a46035e16b30b4bc8f505803659a"><gtr:id>2339a46035e16b30b4bc8f505803659a</gtr:id><gtr:otherNames>Nambiar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>56e02dca6a9ba6.01796995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A187E4-4AC4-4E15-9DB1-2E4113932EC2</gtr:id><gtr:title>Statistics, Science and Public Policy</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>HhB9WpU5QNw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62C61DBE-0933-49A4-8892-0E3791B0F0F5</gtr:id><gtr:title>Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56cdc799867d97.25233699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00DF06D4-BD7B-429D-9857-CF7BACA91D1F</gtr:id><gtr:title>Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia.</gtr:title><gtr:parentPublicationTitle>The Medical journal of Australia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a04bd5ce557b34fa4b36fb8d74adc7d"><gtr:id>8a04bd5ce557b34fa4b36fb8d74adc7d</gtr:id><gtr:otherNames>Hellard ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0025-729X</gtr:issn><gtr:outcomeId>pm_15241_21_22676879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C196A5D6-9F7A-448F-9D4A-67BDD4646227</gtr:id><gtr:title>Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d582accefa04f804d6bab230d9dd36e"><gtr:id>5d582accefa04f804d6bab230d9dd36e</gtr:id><gtr:otherNames>Martin NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>doi_15241__hep_26431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA1A9654-7421-4E75-AEF0-BE3BDF14CC99</gtr:id><gtr:title>Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn><gtr:outcomeId>56e02dc9d32523.42012897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B42EE31-4984-4AE8-ABC9-3A22ED828B71</gtr:id><gtr:title>Mortality in the Melbourne injecting drug user cohort study (MIX).</gtr:title><gtr:parentPublicationTitle>Harm reduction journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2339a46035e16b30b4bc8f505803659a"><gtr:id>2339a46035e16b30b4bc8f505803659a</gtr:id><gtr:otherNames>Nambiar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1477-7517</gtr:issn><gtr:outcomeId>56e02dca0832c9.20371722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C2B4C24-AF4C-40AB-9CAD-E1A27A67D50D</gtr:id><gtr:title>The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/480692b783d5dc3d86f8c1680ef15523"><gtr:id>480692b783d5dc3d86f8c1680ef15523</gtr:id><gtr:otherNames>Davoli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56e02dcac8ca04.50718747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70B81968-B185-4CA7-9F97-1F1F245737A2</gtr:id><gtr:title>Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d522e570384bb31e07c84d7a03b790"><gtr:id>e4d522e570384bb31e07c84d7a03b790</gtr:id><gtr:otherNames>White M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56cdc799544b15.14546026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C274474A-EED7-4E3C-B20A-D62CCECAA0A6</gtr:id><gtr:title>Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1a4b72a97dc63d32c188d74dd0d458"><gtr:id>6c1a4b72a97dc63d32c188d74dd0d458</gtr:id><gtr:otherNames>Larney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>56e02dcae6a222.90518236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BEFBC9E-87BE-45F5-8680-934B38E6DF7F</gtr:id><gtr:title>Premature mortality in Scottish injecting drug users: a life-history approach.</gtr:title><gtr:parentPublicationTitle>Scottish medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/016becdd078a127193a0b99d0246fddf"><gtr:id>016becdd078a127193a0b99d0246fddf</gtr:id><gtr:otherNames>Copeland L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-9330</gtr:issn><gtr:outcomeId>pm_13583_23_22408214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D101553-CF35-478E-9516-BC9D78B6E2E6</gtr:id><gtr:title>Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: placing back-calculations in a formal statistical framework.</gtr:title><gtr:parentPublicationTitle>The Science of the total environment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0048-9697</gtr:issn><gtr:outcomeId>544d3b7572b9a1.03382916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57549B13-B5D5-455C-9F8B-456F33631C69</gtr:id><gtr:title>Errors in reported degrees and respondent driven sampling: implications for bias.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531e490605bdca10c1b955f966b3cfd1"><gtr:id>531e490605bdca10c1b955f966b3cfd1</gtr:id><gtr:otherNames>Mills HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>544d3b76731f47.81492632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5336F6C7-38B1-4CAD-8F5C-F4CE51ADC8C6</gtr:id><gtr:title>Confounding in longitudinal studies in addiction treatment research.</gtr:title><gtr:parentPublicationTitle>Addiction research &amp; theory</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38db94df6d6f87f36e558adffef05d4"><gtr:id>c38db94df6d6f87f36e558adffef05d4</gtr:id><gtr:otherNames>Pierce M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58b591d345b3f5.14011978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4880AF2F-577F-4425-AA54-0B25D0E4CE44</gtr:id><gtr:title>Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review</gtr:title><gtr:parentPublicationTitle>The Lancet Global Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4e58926b7b60434f70ad8cc2b0a77c5"><gtr:id>b4e58926b7b60434f70ad8cc2b0a77c5</gtr:id><gtr:otherNames>Degenhardt L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a775cb1f1c242.77801998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC3666A6-68AE-419D-BC1E-AC3C4199673C</gtr:id><gtr:title>Promoting recovery and preventing drug-related mortality: competing risks?</gtr:title><gtr:parentPublicationTitle>Journal of public health (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1741-3842</gtr:issn><gtr:outcomeId>pm_13583_23_21788295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>690A6E71-3613-468B-9868-F44B369660A0</gtr:id><gtr:title>Pathways through opiate use and offending: A systematic review.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7eb1eab67f3c3118a268d0ca66abf0ee"><gtr:id>7eb1eab67f3c3118a268d0ca66abf0ee</gtr:id><gtr:otherNames>Hayhurst KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>585d4bea49f086.71065985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4764859F-568B-47CB-B06E-9D43724098B7</gtr:id><gtr:title>Risk adjustment of heroin treatment outcomes for comparative performance assessment in England.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4797e3397f62e9136216ecfc151bb8b"><gtr:id>c4797e3397f62e9136216ecfc151bb8b</gtr:id><gtr:otherNames>Marsden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>pm_15241_21_22690731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD6C6A05-FD58-4192-B952-9E2B4960F284</gtr:id><gtr:title>Low incidence of hepatitis C virus among prisoners in Scotland.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15506d85f8bee4016b396e7203341775"><gtr:id>15506d85f8bee4016b396e7203341775</gtr:id><gtr:otherNames>Taylor A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>doi_15241__add_12107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2754A312-08B6-4A64-A0FD-5F2D51872BE4</gtr:id><gtr:title>Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfd3a6d4133940d4cf95819a7bcc108d"><gtr:id>dfd3a6d4133940d4cf95819a7bcc108d</gtr:id><gtr:otherNames>MacArthur GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_13583_23_23038795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A62D6E29-8897-4CD0-86D1-9F43B26D4ABB</gtr:id><gtr:title>Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>doi_15241_12_03932_x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69B0FCB7-0B98-443E-BCA5-356F3E9B78DB</gtr:id><gtr:title>Script in a Day intervention for individuals who are injecting opioids: a feasibility randomized control trial.</gtr:title><gtr:parentPublicationTitle>Journal of public health (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d792530d4f63ac3d567f39e207905eb"><gtr:id>7d792530d4f63ac3d567f39e207905eb</gtr:id><gtr:otherNames>Beattie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-3842</gtr:issn><gtr:outcomeId>56e02dc9a38270.25157691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA0B286-E635-4F69-A13E-C2E29D0C6E76</gtr:id><gtr:title>Mephedrone and cocaine: clues from Army testing.</gtr:title><gtr:parentPublicationTitle>Straight Statistics (http://www.straightstatistics.org/article/mephedrone-and-cocaine-clues-army-testing)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ac98506dde675e8a4fdb5014541030"><gtr:id>f0ac98506dde675e8a4fdb5014541030</gtr:id><gtr:otherNames>Bird, Sheila</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>qbGm4hoMDzA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>481C301D-EDD0-47B4-9B87-4ECB20900F5D</gtr:id><gtr:title>Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38db94df6d6f87f36e558adffef05d4"><gtr:id>c38db94df6d6f87f36e558adffef05d4</gtr:id><gtr:otherNames>Pierce M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56cdc799ad4d96.96694481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92074930-02A3-4C34-9118-FD3B26DBDD6A</gtr:id><gtr:title>The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848f1015824dc5341307815c363a8a06"><gtr:id>848f1015824dc5341307815c363a8a06</gtr:id><gtr:otherNames>Nosyk B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56e02dca8705d3.74206684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D52FEDAA-5940-4833-91C3-CA5FCD4B0775</gtr:id><gtr:title>: An
 
 Package for Bayesian Analysis of Complete and Incomplete Contingency Tables</gtr:title><gtr:parentPublicationTitle>Journal of Statistical Software</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7060ecb3974768556f59427d16cb8e9"><gtr:id>f7060ecb3974768556f59427d16cb8e9</gtr:id><gtr:otherNames>Overstall A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5458d3e9267d88.74852032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB1732B-8707-4281-9241-4E3BEC4F3A0E</gtr:id><gtr:title>Counting the dead: properly and promptly.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d025e62da4d020fd03bc4c31682833"><gtr:id>91d025e62da4d020fd03bc4c31682833</gtr:id><gtr:otherNames>Bird SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>DGE3ckrQC8a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41199CC5-7D5D-4E62-96B9-5482F0A0067C</gtr:id><gtr:title>HCV treatment as prevention in prison: key issues.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d582accefa04f804d6bab230d9dd36e"><gtr:id>5d582accefa04f804d6bab230d9dd36e</gtr:id><gtr:otherNames>Martin NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>544d3b75d79e68.05795363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>394D61D4-B250-4580-89AD-8AE29FA5167C</gtr:id><gtr:title>A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2339a46035e16b30b4bc8f505803659a"><gtr:id>2339a46035e16b30b4bc8f505803659a</gtr:id><gtr:otherNames>Nambiar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a775f0612a729.06048997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6888865-BB01-4564-84FC-69D319516B26</gtr:id><gtr:title>The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/322459931b7fda591d6be0ad9ddc4dde"><gtr:id>322459931b7fda591d6be0ad9ddc4dde</gtr:id><gtr:otherNames>Dietze P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>pm_13583_23_22989499</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49003E85-67D1-4552-BC19-6BAF79BC57F1</gtr:id><gtr:title>Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38db94df6d6f87f36e558adffef05d4"><gtr:id>c38db94df6d6f87f36e558adffef05d4</gtr:id><gtr:otherNames>Pierce M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>5a775f05235cf8.70435464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82426A62-9014-4B07-877B-C1F8AB5D9A4E</gtr:id><gtr:title>Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d582accefa04f804d6bab230d9dd36e"><gtr:id>5d582accefa04f804d6bab230d9dd36e</gtr:id><gtr:otherNames>Martin NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>doi_15241_cid_cit296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DA28DF2-6AE4-4EBE-B9CB-BD6A31584ECE</gtr:id><gtr:title>Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0640257da208e905db9f4ca7f6ca22fb"><gtr:id>0640257da208e905db9f4ca7f6ca22fb</gtr:id><gtr:otherNames>Overstall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>K4WQ8MySAas</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDD5CD45-E90C-4E3E-BAB8-B94D78B3AC09</gtr:id><gtr:title>Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531e490605bdca10c1b955f966b3cfd1"><gtr:id>531e490605bdca10c1b955f966b3cfd1</gtr:id><gtr:otherNames>Mills HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>pm_15241_21_22728045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD2053FC-98F5-4B1D-AA81-971E8C06916F</gtr:id><gtr:title>The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_15241_21_22457292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A675282E-C61A-480E-BBB4-4A69E06E5648</gtr:id><gtr:title>Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.</gtr:title><gtr:parentPublicationTitle>The International journal on drug policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfd3a6d4133940d4cf95819a7bcc108d"><gtr:id>dfd3a6d4133940d4cf95819a7bcc108d</gtr:id><gtr:otherNames>MacArthur GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0955-3959</gtr:issn><gtr:outcomeId>544d3b753a86d7.72298895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A09E4F9-67FD-463F-8D3D-E4C6DCD2024E</gtr:id><gtr:title>Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study</gtr:title><gtr:parentPublicationTitle>The Lancet Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3750fbcc4117869265badeb61173fd4"><gtr:id>a3750fbcc4117869265badeb61173fd4</gtr:id><gtr:otherNames>Kimber J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e02dca466615.46880761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C704FA56-2373-456E-932B-FBD4C5187585</gtr:id><gtr:title>Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates.</gtr:title><gtr:parentPublicationTitle>Addiction research &amp; theory</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0d3cf730dd45838345aed36a7c7886c"><gtr:id>e0d3cf730dd45838345aed36a7c7886c</gtr:id><gtr:otherNames>King R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>JnHGZ5vRPBH</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000021</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>